ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,358Medicare Part D Prescriptions Filled, Including Refills

Rank: 175 out of 336

$467K Total Retail Price of All Prescriptions

Rank: 158 out of 336

298 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 6,407 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 273 223 S3 1 2
PRAVASTATIN SODIUM 272 241 2 10
AMLODIPINE BESYLATE 271 249 3 1
METFORMIN HCL 242 209 4 8
LEVOTHYROXINE SODIUM 224 191 5 7
OMEPRAZOLE 206 187 6 3
LISINOPRIL 204 173 7 6
HYDROCHLOROTHIAZIDE 174 168 8 12
FUROSEMIDE 167 140 9 4
RAMIPRIL 141 129 10 84
LOSARTAN POTASSIUM 139 116 11 22
ATORVASTATIN CALCIUM 135 111 12 14
GABAPENTIN 127 111 13 11
CARVEDILOL 120 100 14 13
SIMVASTATIN 114 99 15 5
CRESTOR 112 90 16 25
NEXIUM 108 79 17 24
POTASSIUM CHLORIDE 107 95 18 9
DIOVAN 100 100 19 31
GLIMEPIRIDE 94 84 20 29
METOPROLOL TARTRATE 88 87 21 16
FLUTICASONE PROPIONATE 85 71 22 49
WARFARIN SODIUM 81 81 23 17
METOPROLOL SUCCINATE 80 70 24 15
LANTUS SOLOSTAR 76 73 25 124
PREDNISONE 75 73 26 48
LOSARTAN-HYDROCHLOROTHIAZIDE 75 61 26 45
ALLOPURINOL 74 65 28 30
NAMENDA 74 74 28 39
CLOPIDOGREL 70 62 30 28
CITALOPRAM HBR 68 29 31 21
PANTOPRAZOLE SODIUM 65 65 32 40
JANUVIA 65 65 32 67
LEVOFLOXACIN 60 51 34 93
ZETIA 59 57 35 74
DONEPEZIL HCL 58 58 36 27
PLAVIX 57 49 37 37
CARISOPRODOL 56 46 R 38 63
VENLAFAXINE HCL ER 55 47 39 100
AMITRIPTYLINE HCL 55 53 R 39 57
EXELON 54 54 41 154
ZOLPIDEM TARTRATE 53 42 42 18
SERTRALINE HCL 53 50 42 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.